Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment
Authors
Keywords
-
Journal
Future Oncology
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2020-02-26
DOI
10.2217/fon-2019-0722
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: a multi-database cohort study
- (2019) Seoyoung C. Kim et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Survivin a pivotal antiapoptotic protein in rheumatoid arthritis
- (2019) Parisa Zafari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis
- (2019) Jiang-lin Wang et al. CLINICAL RHEUMATOLOGY
- Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors
- (2018) Merav Lidar et al. AUTOIMMUNITY REVIEWS
- Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
- (2018) François-Xavier Danlos et al. EUROPEAN JOURNAL OF CANCER
- Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome
- (2018) Alina Klein et al. HEMATOLOGICAL ONCOLOGY
- Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen
- (2018) Laura C. Cappelli et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden
- (2018) Malin C. Erlandsson et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience
- (2018) Michael D. Richter et al. Arthritis & Rheumatology
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Inflammation is a key contributor to ovarian cancer cell seeding
- (2018) Dongyu Jia et al. Scientific Reports
- Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis
- (2017) Caroline Wasén et al. JOURNAL OF AUTOIMMUNITY
- Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry
- (2017) David Fiorentino et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis
- (2017) Akshjot Puri et al. MELANOMA RESEARCH
- Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
- (2017) Jarushka Naidoo et al. ONCOLOGIST
- Arthritis after cancer immunotherapy: symptom duration and treatment response
- (2017) Melanie H. Smith et al. ARTHRITIS CARE & RESEARCH
- Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
- (2017) Laura C. Cappelli et al. ARTHRITIS CARE & RESEARCH
- Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice
- (2017) Hjalmar Wadström et al. JAMA Internal Medicine
- Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing
- (2017) Danna Chen et al. Scientific Reports
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient With Advanced Non–Small Cell Lung Cancer: A Case Report
- (2016) Konstantinos Syrigos et al. ANNALS OF INTERNAL MEDICINE
- The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma
- (2016) B. Lee et al. ANNALS OF ONCOLOGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
- (2016) E. Zucca et al. BLOOD
- Rheumatoid Arthritis: Notable Biomarkers Linking to Chronic Systemic Conditions and Cancer
- (2016) Oore-ofe O. Olumuyiwa-Akeredolu et al. CURRENT PHARMACEUTICAL DESIGN
- Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs
- (2016) Mary Chester Wasko et al. ARTHRITIS CARE & RESEARCH
- Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
- (2016) Tae-Hwe Heo et al. Oncotarget
- Underlying Autoimmune Disease Is Not a Contraindication to the Use of Ipilimumab
- (2016) Mary L. Disis JAMA Oncology
- Survivin: A molecular biomarker in cancer
- (2015) RD Mittal et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- Characteristics and Prognosis of Colorectal Cancer Associated With Rheumatic Disease
- (2015) Junko Kishikawa et al. INTERNATIONAL SURGERY
- Arthritis and Tenosynovitis Associated With the Anti-PD1 Antibody Pembrolizumab in Metastatic Melanoma
- (2015) Matthew M. K. Chan et al. JOURNAL OF IMMUNOTHERAPY
- Recognizing Rheumatoid Arthritis
- (2015) Too Chun-Lai et al. MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma
- (2014) F. Stephen Hodi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement
- (2014) Chun Jing Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
- (2014) Sabrina Ceeraz et al. ARTHRITIS RESEARCH & THERAPY
- B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
- (2014) Serena Bugatti et al. Biomed Research International
- Expression of Survivin in Patients With Refractory Rheumatoid Arthritis in a Chinese Population
- (2014) Xian Ming Long Archives of Rheumatology
- Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs
- (2013) Daniel H. Solomon et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry
- (2012) Lene Dreyer et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of the CTLA-4/CD28 axis on the processes of joint inflammation in rheumatoid arthritis
- (2012) Dezsö Körmendy et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases
- (2012) Kevin Haynes et al. ARTHRITIS AND RHEUMATISM
- Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy
- (2012) Maria A. Lopez-Olivo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort
- (2011) Elizabeth H Ruder et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials
- (2011) Andrew E. Thompson et al. ARTHRITIS AND RHEUMATISM
- Extra-articular manifestations of rheumatoid arthritis: An update
- (2011) Marcella Prete et al. AUTOIMMUNITY REVIEWS
- Pharmacology and cellular/molecular mechanisms of action of aspirin and Non-aspirin NSAIDs in colorectal cancer
- (2011) Karsten Schrör BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Activation of epithelial STAT3 regulates intestinal homeostasis
- (2011) Clemens Neufert et al. CELL CYCLE
- Tumor markers are elevated in patients with rheumatoid arthritis and do not indicate presence of cancer
- (2011) Samuel BERGAMASCHI et al. International Journal of Rheumatic Diseases
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis
- (2011) Anniella Isgren et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Increased expression of proto-oncogene survivin predicts joint destruction and persistent disease activity in early rheumatoid arthritis
- (2010) Björn Svensson et al. ANNALS OF MEDICINE
- Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production
- (2010) J. P. van Hamburg et al. ARTHRITIS AND RHEUMATISM
- Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis
- (2010) Karin Hellgren et al. ARTHRITIS AND RHEUMATISM
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- Increased Extracellular Survivin in the Synovial Fluid of Rheumatoid Arthritis Patients: Fibroblast-like Synoviocytes as a Potential Source of Extracellular Survivin
- (2010) Joong Kyong Ahn et al. INFLAMMATION
- Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6–STAT3 signaling pathway
- (2010) Yun Tian et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer
- (2010) Maximilian J. Waldner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
- (2009) Y. Li et al. GUT
- Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis
- (2009) Bailin Liang et al. Journal of Inflammation-London
- The Immunopathogenesis of Rheumatoid Arthritis
- (2008) John B. Imboden Annual Review of Pathology-Mechanisms of Disease
- Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses
- (2008) Minoru Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Co-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept
- (2008) Ugo Fiocco et al. AUTOIMMUNITY REVIEWS
- CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
- (2008) A. Bashey et al. BLOOD
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
- (2008) Willscott E. Naugler et al. TRENDS IN MOLECULAR MEDICINE
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
- (2008) Allison L Smitten et al. ARTHRITIS RESEARCH & THERAPY
- Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer
- (2007) Duygu Derin et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started